Close Mobile Navigation

WELCOME TO THE
KEYTRUDA
PATIENT SUPPORT
WEBSITE


GET ACCESS

To access this website, you must be a current patient being treated with KEYTRUDA in Australia and be 18 years or older.

  • The access code is supplied within the KEYTRUDA patient booklet which you can request from your healthcare professional, if you don’t have a copy.
  • Alternatively, please contact your treating healthcare professional to request the access code to access this website.

Registered users are no longer required to sign in using their registered email address and password. Please enter the access code to continue accessing this website.

The access code entered is not valid, please try again or contact your Healthcare Professional.

Terms of Use | Contact Us | Privacy Policy | Accessibility

MSD Medical Information or to report product complaints (including adverse events): 1800 818 553

This educational website is sponsored by Merck Sharp & Dohme (Australia) Pty Ltd. Information displayed on this website is only intended for Australian residents who are 18 years or older and are currently being treated with KEYTRUDA and as such, its contents have been designed to comply with Australian laws and regulations. The information on this website is educational only and is not intended to be used for any self-diagnosis purposes nor to replace the advice of your Doctor or healthcare professional. Please consult your Doctor or healthcare professional for further information on KEYTRUDA. Use and access of this website is subject to the terms and conditions set out in our Legal Agreement and Privacy Policy.

Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
Merck Sharp & Dohme (Australia) Pty Limited. Level 1 – Building A, 26 Talavera Road, Macquarie Park NSW 2113.
AU-KEY-00559. Issued March 2024.

Accessibility icon

LEARN ABOUT KEYTRUDA

Learn about KEYTRUDA; how it acts, how it is given, and some of the effects it has when used to treat your cancer.

ABOUT KEYTRUDA

WHAT IS KEYTRUDA?

KEYTRUDA is a medicine used to treat cancer.

Your doctor will prescribe KEYTRUDA if you have a type of cancer that is suitable for treatment with KEYTRUDA.

KEYTRUDA contains the active medicine called pembrolizumab. It works with your immune system, helping it to find and destroy cancer cells.

For more information on KEYTRUDA, download the patient brochure

References

KEYTRUDA Australian Consumer Medicine Information, www.msdinfo.com.au/keytrudacmi

For further information about your condition or treatment consult your healthcare professional or refer to the Consumer Medicine Information for KEYTRUDA.

AU-KEY-00459. Issued September 2023.

Terms of Use | Contact Us | Privacy Policy | Accessibility

MSD Medical Information or to report product complaints (including adverse events): 1800 818 553

This educational website is sponsored by Merck Sharp & Dohme (Australia) Pty Ltd. Information displayed on this website is only intended for Australian residents who are 18 years or older and are currently being treated with KEYTRUDA and as such, its contents have been designed to comply with Australian laws and regulations. The information on this website is educational only and is not intended to be used for any self-diagnosis purposes nor to replace the advice of your Doctor or healthcare professional. Please consult your Doctor or healthcare professional for further information on KEYTRUDA. Use and access of this website is subject to the terms and conditions set out in our Legal Agreement and Privacy Policy.

Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
Merck Sharp & Dohme (Australia) Pty Limited. Level 1 – Building A, 26 Talavera Road, Macquarie Park NSW 2113.
AU-KEY-00559. Issued March 2024.

Accessibility icon